PharmAla Biotech Holdings (OTC:MDXXF) has announced advancement of its contract with UT Health San Antonio for the STRONG STAR Consortium study, ...
News
- PharmAla Develops New MDMA Dosage for $10M DoD-Funded PTSD Study in Military Personnel
- Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update
(Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 ... Presented two posters at the San Antonio Breast Cancer Symposium.
- Ulta Beauty World to Debut in San Antonio this Spring - MarketScreener
Biotechnology · Bionic engineering · Cybersecurity · Rankings · Top Movers ... San Antonio, TX, this spring. Mark your calendars for April 26, 2025 ...
- PharmAla to supply STRONG STAR at UT Health San Antonio, with novel dosage form of ...
PharmAla to supply STRONG STAR at UT Health San Antonio, with novel dosage form of LaNeo™ MDMA. PharmAla Biotech - (GLOBE NEWSWIRE); Feb 27, 2025; 13 ...
- PharmAla Advances MDMA Trial for Military PTSD Treatment - TipRanks.com
PharmAla Biotech Holdings Inc. has announced the progression of its contract with the University of Texas Health Science Center at San Antonio, funded ...